FTC’s sham petition loss to Shire tees up potential federal court troubles
Drugmaker Shire has defeated a Federal Trade Commission lawsuit claiming that it delayed generic versions of the gastrointestinal drug Vancocin, despite a federal judge ruling that the company’s past conduct could...To view the full article, register now.
Already a subscriber? Click here to view full article